Status:
COMPLETED
BLI Based Adenoma Surveillance Strategy
Lead Sponsor:
Portsmouth Hospitals NHS Trust
Collaborating Sponsors:
King's College Hospital NHS Trust
Luzerner Kantonsspital
Conditions:
Colorectal Polyp
Eligibility:
All Genders
18+ years
Brief Summary
Bowel cancer is the third most common cancer in the UK. It develops through smaller growths in the bowel called polyps. Early recognition and removal of these polyps result in prevention of developing...
Detailed Description
Advanced endoscopic imaging can facilitate the characterisation of neoplastic and non-neoplastic polyps. Accurate identification of small non-neoplastic polyps (e.g. rectosigmoid hyperplastic polyps) ...
Eligibility Criteria
Inclusion
- \> 18 years of age Able to provide informed consent
Exclusion
- History of polyposis syndrome History of Inflammatory bowel disease History of poor bowel prep
Key Trial Info
Start Date :
October 16 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 15 2022
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT04111601
Start Date
October 16 2019
End Date
October 15 2022
Last Update
November 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Portsmouth Hospital NHS Trust
Portsmouth, Hampshire, United Kingdom, PO6 3LY